2m 2m 2m 2m 2m 2m 2m
IBIO (IBIO)
NASDAQ
$1.50+$0.05 (+3.38%)
Price as of Jul 14, 2026 8:32 AM EDT- $72.0MMarket Cap
- 89.54%1-Year Change
- BiotechnologyIndustry
IBIO (IBIO)
$1.50+$0.05 (+3.38%)
IBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.45 | ||
Change | -$0.06 (-3.97%) | ||
Open | $1.48 | ||
High | $1.56 | ||
Low | $1.45 | ||
Previous Close | $1.51 | ||
Volume | 1,076,544 | ||
30-Day Average Volume | 1,128,534 | ||
1-Week Change | -10.49% | ||
1-Month Change | -14.20% | ||
1-Year Change | 89.54% | ||
3-Year Change | -87.72% | ||
5-Year Change | -99.79% | ||
Fundamentals | |||
Shares Outstanding | 49.7M | ||
Total Assets | $85.8M | ||
Market Cap | $72.0M | ||
Enterprise Value | $25.2M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$7.7M | ||
Free Cash Flow | -$6.1M | ||
EBIT | -$7.7M | ||
EBITDA | -$7.7M | ||
Net Working Capital | $70.7M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -24 | ||
PEG | -1 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 11/29/2023 | ||